Vaccitech
Latest round
- Series B
Last raised
- Mar 2021
Total raised
- $282M
Investors
- 11
About Vaccitech
Vaccitech Limited, founded in 2016 and headquartered in Oxford, UK, specializes in the development of antigen-specific immunotherapeutics.Vaccitech Limited's core products include VTP-200 and VTP-300, designed to treat chronic viral infections, autoimmune diseases, and cancer.30. The firm aims to enhance its immunotherapy pipeline, including potential new product launches in the upcoming years. The expansion efforts will target North America and Europe, leveraging the growing demand for advanced therapeutic solutions.
Who invested in Vaccitech
11 investors across 4 rounds
See all investors in Vaccitech
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Vaccitech
Who invested in Vaccitech?
Vaccitech has 11 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Vaccitech raised?
Vaccitech has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Vaccitech last raise money?
Vaccitech's most recent round on record is a Series B, in Mar 2021.
What does Vaccitech do?
Vaccitech Limited, founded in 2016 and headquartered in Oxford, UK, specializes in the development of antigen-specific immunotherapeutics.
Where is Vaccitech headquartered?
Vaccitech is headquartered in Oxford, UK.
Which VCs invest in companies like Vaccitech?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at Vaccitech's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Vaccitech? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.